These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15652203)

  • 1. A new scleroglucan/borax hydrogel: swelling and drug release studies.
    Coviello T; Grassi M; Palleschi A; Bocchinfuso G; Coluzzi G; Banishoeib F; Alhaique F
    Int J Pharm; 2005 Jan; 289(1-2):97-107. PubMed ID: 15652203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on a new scleroglucan/borax hydrogel: structure and drug release.
    Palleschi A; Coviello T; Bocchinfuso G; Alhaique F
    Int J Pharm; 2006 Sep; 322(1-2):13-21. PubMed ID: 16806759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new polysaccharidic gel matrix for drug delivery: preparation and mechanical properties.
    Coviello T; Alhaique F; Parisi C; Matricardi P; Bocchinfuso G; Grassi M
    J Control Release; 2005 Feb; 102(3):643-56. PubMed ID: 15681086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and rheological characterization of Scleroglucan/borax hydrogel for drug delivery.
    Coviello T; Coluzzi G; Palleschi A; Grassi M; Santucci E; Alhaique F
    Int J Biol Macromol; 2003 Sep; 32(3-5):83-92. PubMed ID: 12957304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery matrices based on scleroglucan/alginate/borax gels.
    Matricardi P; Onorati I; Coviello T; Alhaique F
    Int J Pharm; 2006 Jun; 316(1-2):21-8. PubMed ID: 16554128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleroglucan/borax: characterization of a novel hydrogel system suitable for drug delivery.
    Coviello T; Grassi M; Lapasin R; Marino A; Alhaique F
    Biomaterials; 2003 Jul; 24(16):2789-98. PubMed ID: 12711526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleroglucan sustained-release oral preparations. Part I. In vitro experiments.
    Touitou E; Alhaique F; Riccieri FM; Riccioni G; Santucci E
    Drug Des Deliv; 1989 Dec; 5(2):141-8. PubMed ID: 2577984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleroglucan-borax hydrogel: a flexible tool for redox protein immobilization.
    Frasconi M; Rea S; Matricardi P; Favero G; Mazzei F
    Langmuir; 2009 Sep; 25(18):11097-104. PubMed ID: 19694483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guar gum and scleroglucan interactions with borax: experimental and theoretical studies of an unexpected similarity.
    Bocchinfuso G; Mazzuca C; Sandolo C; Margheritelli S; Alhaique F; Coviello T; Palleschi A
    J Phys Chem B; 2010 Oct; 114(41):13059-68. PubMed ID: 20863102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of pH on the Scleroglucan and Scleroglucan/Borax Systems.
    Mazzuca C; Bocchinfuso G; Palleschi A; Conflitti P; Grassi M; Di Meo C; Alhaique F; Coviello T
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28282944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline.
    Vendruscolo CW; Andreazza IF; Ganter JL; Ferrero C; Bresolin TM
    Int J Pharm; 2005 May; 296(1-2):1-11. PubMed ID: 15885450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-polymer interactions and their effect on thermoresponsive poly(N-isopropylacrylamide) drug delivery systems.
    Coughlan DC; Corrigan OI
    Int J Pharm; 2006 Apr; 313(1-2):163-74. PubMed ID: 16517105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of drugs from multi-component biomaterials.
    Zalfen AM; Nizet D; Jérôme C; Jérôme R; Frankenne F; Foidart JM; Maquet V; Lecomte F; Hubert P; Evrard B
    Acta Biomater; 2008 Nov; 4(6):1788-96. PubMed ID: 18583206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroglucan sustained release oral preparations. Part II. Effects of additives.
    Alhaique F; Beltrami E; Riccieri FM; Santucci E; Touitou E
    Drug Des Deliv; 1990 Mar; 5(3):249-57. PubMed ID: 1670505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli responsive self-assembled hydrogel of a low molecular weight free dipeptide with potential for tunable drug delivery.
    Panda JJ; Mishra A; Basu A; Chauhan VS
    Biomacromolecules; 2008 Aug; 9(8):2244-50. PubMed ID: 18624454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
    Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
    Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.